Display options
Share it on

Cancers (Basel). 2021 Oct 14;13(20). doi: 10.3390/cancers13205151.

Hepatocyte Polyploidy: Driver or Gatekeeper of Chronic Liver Diseases.

Cancers

Romain Donne, Flora Sangouard, Séverine Celton-Morizur, Chantal Desdouets

Affiliations

  1. Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  2. Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY 10029, USA.
  3. Icahn School of Medicine at Mount Sinai, The Precision Immunology Institute, New York, NY 10029, USA.
  4. Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  5. Laboratory of Proliferation, Stress and Liver Physiopathology, Centre de Recherche des Cordeliers, F-75006 Paris, France.
  6. Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, F-75006 Paris, France.

PMID: 34680300 PMCID: PMC8534039 DOI: 10.3390/cancers13205151

Abstract

Polyploidy, also known as whole-genome amplification, is a condition in which the organism has more than two basic sets of chromosomes. Polyploidy frequently arises during tissue development and repair, and in age-associated diseases, such as cancer. Its consequences are diverse and clearly different between systems. The liver is a particularly fascinating organ in that it can adapt its ploidy to the physiological and pathological context. Polyploid hepatocytes are characterized in terms of the number of nuclei per cell (cellular ploidy; mononucleate/binucleate hepatocytes) and the number of chromosome sets in each nucleus (nuclear ploidy; diploid, tetraploid, octoploid). The advantages and disadvantages of polyploidy in mammals are not fully understood. About 30% of the hepatocytes in the human liver are polyploid. In this review, we explore the mechanisms underlying the development of polyploid cells, our current understanding of the regulation of polyploidization during development and pathophysiology and its consequences for liver function. We will also provide data shedding light on the ways in which polyploid hepatocytes cope with centrosome amplification. Finally, we discuss recent discoveries highlighting the possible roles of liver polyploidy in protecting against tumor formation, or, conversely, contributing to liver tumorigenesis.

Keywords: DNA damage response; cell cycle; centrosome; hepatocellular carcinoma; hepatocytes; polyploidy

References

  1. Development. 2013 Jan 1;140(1):3-12 - PubMed
  2. Cell. 2014 Aug 14;158(4):833-848 - PubMed
  3. Hepatology. 2016 Aug;64(2):599-615 - PubMed
  4. Nat Commun. 2016 Apr 22;7:11400 - PubMed
  5. Genes Dev. 2018 May 1;32(9-10):620-638 - PubMed
  6. Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):10004-9 - PubMed
  7. Cell Cycle. 2010 Feb 1;9(3):460-6 - PubMed
  8. Nature. 2005 Oct 13;437(7061):1043-7 - PubMed
  9. Endocr Relat Cancer. 2017 Sep;24(9):T97-T106 - PubMed
  10. Am J Pathol. 2014 Feb;184(2):322-31 - PubMed
  11. Clin Gastroenterol Hepatol. 2011 Jun;9(6):524-530.e1; quiz e60 - PubMed
  12. Nat Commun. 2018 Apr 9;9(1):1344 - PubMed
  13. Cancer Res. 2004 Oct 15;64(20):7629-33 - PubMed
  14. Am J Pathol. 2019 Jun;189(6):1241-1255 - PubMed
  15. Nat Rev Mol Cell Biol. 2014 Mar;15(3):197-210 - PubMed
  16. Annu Rev Cell Dev Biol. 2012;28:29-58 - PubMed
  17. Nat Rev Cancer. 2019 Jan;19(1):32-45 - PubMed
  18. Genes Dev. 2017 Jan 1;31(1):34-45 - PubMed
  19. N Engl J Med. 2017 Jun 1;376(22):2109-2121 - PubMed
  20. Carcinogenesis. 2018 Jul 30;39(8):993-1005 - PubMed
  21. Nat Cell Biol. 2012 Nov;14(11):1181-91 - PubMed
  22. Anat Rec. 1954 May;119(1):11-33 - PubMed
  23. Nat Genet. 2018 Aug;50(8):1189-1195 - PubMed
  24. Nat Rev Gastroenterol Hepatol. 2019 Jul;16(7):411-428 - PubMed
  25. Gastroenterology. 2012 Jan;142(1):25-8 - PubMed
  26. Differentiation. 1995 Jul;59(1):35-42 - PubMed
  27. Genes Dev. 2006 Oct 1;20(19):2687-700 - PubMed
  28. Nature. 2009 Jul 9;460(7252):278-82 - PubMed
  29. Semin Cell Dev Biol. 2010 Dec;21(9):881-91 - PubMed
  30. Hepatology. 2019 Mar;69(3):1242-1258 - PubMed
  31. Carcinogenesis. 2006 Feb;27(2):337-43 - PubMed
  32. J Gastroenterol Hepatol. 1991 Nov-Dec;6(6):615-24 - PubMed
  33. Semin Cell Dev Biol. 2013 Apr;24(4):370-9 - PubMed
  34. Liver. 2002 Oct;22(5):419-25 - PubMed
  35. Mol Cell Oncol. 2017 Jan 5;4(2):e1277293 - PubMed
  36. Genes Dev. 2009 Nov 1;23(21):2461-77 - PubMed
  37. Cancer. 1991 Feb 15;67(4):939-44 - PubMed
  38. J Cell Sci. 2007 Oct 15;120(Pt 20):3633-9 - PubMed
  39. Sci Rep. 2017 Dec 1;7(1):16762 - PubMed
  40. Cell. 2010 Apr 2;141(1):81-93 - PubMed
  41. Cancer Res. 2019 Aug 15;79(16):3995-4002 - PubMed
  42. Gut. 2020 Feb;69(2):355-364 - PubMed
  43. Gastroenterology. 2018 Apr;154(5):1421-1434 - PubMed
  44. Trends Cell Biol. 2009 Mar;19(3):111-8 - PubMed
  45. Adv Exp Med Biol. 2010;676:105-22 - PubMed
  46. Dev Cell. 2020 Feb 10;52(3):335-349.e7 - PubMed
  47. Gastroenterology. 2020 May;158(6):1698-1712.e14 - PubMed
  48. Annu Rev Cell Dev Biol. 2011;27:585-610 - PubMed
  49. Ann N Y Acad Sci. 2008;1133:3-25 - PubMed
  50. Curr Biol. 2006 Jun 20;16(12):1194-200 - PubMed
  51. J Clin Invest. 2016 Aug 1;126(8):2955-69 - PubMed
  52. Cancer Cell. 2012 Jun 12;21(6):765-76 - PubMed
  53. Oncogene. 2019 Apr;38(14):2645-2657 - PubMed
  54. Nat Commun. 2021 Jan 28;12(1):645 - PubMed
  55. Nat Rev Genet. 2005 Nov;6(11):836-46 - PubMed
  56. Nat Rev Mol Cell Biol. 2012 Dec;13(12):789-803 - PubMed
  57. Cell Tissue Res. 2017 May;368(2):405-410 - PubMed
  58. Nat Rev Genet. 2017 Jul;18(7):411-424 - PubMed
  59. J Biol Chem. 2003 May 23;278(21):19095-101 - PubMed
  60. Cell Cycle. 2019 Jan;18(1):7-15 - PubMed
  61. J Anat. 1991 Dec;179:169-81 - PubMed
  62. Semin Cancer Biol. 2000 Jun;10(3):161-71 - PubMed
  63. World J Gastroenterol. 2006 Jul 28;12(28):4546-8 - PubMed
  64. Hepatology. 2014 Jul;60(1):349-61 - PubMed
  65. J Clin Invest. 2009 Jul;119(7):1880-7 - PubMed
  66. Nat Rev Mol Cell Biol. 2007 Jun;8(6):451-63 - PubMed
  67. PLoS Genet. 2009 Feb;5(2):e1000385 - PubMed
  68. Chromosoma. 2013 Aug;122(4):305-18 - PubMed
  69. Med Sci (Paris). 2006 Nov;22(11):904-6 - PubMed
  70. Carcinogenesis. 1988 Sep;9(9):1647-55 - PubMed
  71. J Clin Invest. 2015 Mar 2;125(3):981-92 - PubMed
  72. Hepatology. 2021 Jan;73(1):303-317 - PubMed
  73. Nat Cell Biol. 2012 Nov;14(11):1192-202 - PubMed
  74. Gut. 2005 Feb;54(2):297-302 - PubMed
  75. Trends Cell Biol. 2013 Nov;23(11):556-66 - PubMed
  76. Curr Opin Genet Dev. 2007 Apr;17(2):157-62 - PubMed
  77. Nat Commun. 2021 Jul 12;12(1):4264 - PubMed
  78. Trends Cell Biol. 2007 May;17(5):215-21 - PubMed
  79. Nature. 2017 Feb 16;542(7641):352-356 - PubMed
  80. Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3826-31 - PubMed
  81. Nature. 2010 Oct 7;467(7316):707-10 - PubMed
  82. Am J Pathol. 1999 Dec;155(6):2135-43 - PubMed
  83. Philos Trans R Soc Lond B Biol Sci. 2014 Sep 5;369(1650): - PubMed
  84. Cancer Sci. 2018 Sep;109(9):2632-2640 - PubMed
  85. J Pathol. 2012 Jan;226(2):338-51 - PubMed
  86. J Biol Chem. 2008 Oct 17;283(42):28729-40 - PubMed
  87. J Biol Chem. 2010 Sep 24;285(39):30282-93 - PubMed
  88. Dev Cell. 2018 Feb 26;44(4):447-459.e5 - PubMed
  89. J Cell Biol. 2007 Jan 15;176(2):183-95 - PubMed
  90. Annu Rev Genet. 2000;34:401-437 - PubMed
  91. Hepatology. 1994 May;19(5):1072-8 - PubMed
  92. Cell. 2016 Nov 17;167(5):1264-1280.e18 - PubMed
  93. EMBO Rep. 2020 Dec 3;21(12):e50893 - PubMed
  94. EMBO J. 2002 Feb 15;21(4):483-92 - PubMed
  95. Cancer. 1994 Jan 15;73(2):281-8 - PubMed
  96. Trends Genet. 2019 Jan;35(1):6-14 - PubMed
  97. Cell. 2014 Apr 24;157(3):565-79 - PubMed
  98. Cancers (Basel). 2017 Dec 28;10(1): - PubMed
  99. Nat Rev Gastroenterol Hepatol. 2020 Jul;17(7):391-405 - PubMed
  100. Nat Commun. 2021 Mar 25;12(1):1896 - PubMed
  101. Nat Rev Cancer. 2007 Dec;7(12):968-76 - PubMed
  102. Nat Genet. 2013 Oct;45(10):1134-40 - PubMed
  103. Biochem Biophys Res Commun. 2006 Apr 21;342(4):1160-7 - PubMed
  104. Annu Rev Nutr. 1996;16:179-203 - PubMed
  105. Elife. 2015 Dec 27;4: - PubMed
  106. Mol Biol Cell. 2001 May;12(5):1315-28 - PubMed
  107. J Virol. 2009 Dec;83(23):12590-600 - PubMed
  108. Oncotarget. 2015 Apr 20;6(11):8430-1 - PubMed
  109. Curr Biol. 2014 Mar 17;24(6):598-608 - PubMed
  110. Curr Biol. 2013 Nov 18;23(22):2224-2232 - PubMed
  111. Nature. 2015 Mar 19;519(7543):349-52 - PubMed
  112. Gastroenterology. 1993 Nov;105(5):1449-54 - PubMed
  113. Nat Commun. 2021 Jan 28;12(1):646 - PubMed
  114. Adv Wound Care (New Rochelle). 2016 Jun 1;5(6):271-278 - PubMed
  115. Science. 2004 May 7;304(5672):843-6 - PubMed
  116. Semin Cell Dev Biol. 2013 Apr;24(4):347-56 - PubMed
  117. EMBO Rep. 2020 Dec 3;21(12):e51922 - PubMed
  118. Nat Rev Mol Cell Biol. 2011 Jun;12(6):385-92 - PubMed
  119. J Med Genet. 1976 Feb;13(1):9-16 - PubMed
  120. Nat Med. 2018 Jul;24(7):908-922 - PubMed
  121. Cell Mol Gastroenterol Hepatol. 2020;9(1):161-183 - PubMed
  122. Nat Rev Mol Cell Biol. 2004 Jan;5(1):45-54 - PubMed
  123. Cell. 2018 Sep 20;175(1):200-211.e13 - PubMed
  124. Comp Biochem Physiol A Mol Integr Physiol. 2003 Mar;134(3):665-73 - PubMed
  125. Nature. 1999 Sep 23;401(6751):341 - PubMed
  126. Nat Rev Genet. 2009 Oct;10(10):725-32 - PubMed
  127. Nat Rev Dis Primers. 2021 Jan 21;7(1):6 - PubMed
  128. Biochem Biophys Res Commun. 2003 Feb 28;302(1):114-20 - PubMed
  129. Clin Liver Dis (Hoboken). 2018 Apr 20;11(4):92-94 - PubMed
  130. Adv Exp Med Biol. 2010;676:93-103 - PubMed
  131. Am J Pathol. 1961 Aug;39:209-20 - PubMed
  132. Development. 2018 Jul 18;145(14): - PubMed
  133. Cell Stem Cell. 2020 Jan 2;26(1):34-47.e3 - PubMed

Publication Types

Grant support